John Lahad

Medicine · Health Sciences

10h-index2.0kcitations18works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(4), Genomics and Chromatin Dynamics(3), Microtubule and mitosis dynamics(3), Prenatal Screening and Diagnostics(3), Endoplasmic Reticulum Stress and Disease(3)

Publications18 total

Supplementary Figure 1 from Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer
2023Open Access
Data from Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer
2023Open Access
Data from Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer
2023Open Access
Supplementary Figure 1 from Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer
2023Open Access
Dreaming a Common Dream, Living a Common Nightmare: Abuses and Rights of Immigrant Workers in the United States, the European Union, and the United Arab Emirates
Houston journal of international law·2009· 2 cited
Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis
PLoS ONE·2009· 60 citedOpen Access
Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer
Cancer Research·2007· 138 cited
A module of negative feedback regulators defines growth factor signaling
Nature Genetics·2007· 481 cited
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer
Cancer Cell·2006· 147 citedOpen Access
Functional Lipidomics
2005· 45 cited
Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer
Proceedings of the National Academy of Sciences·2005· 238 citedOpen Access
Stem cell-ness: a "magic marker" for cancer
Journal of Clinical Investigation·2005· 3 citedOpen Access
Stem cell-ness: a "magic marker" for cancer
Journal of Clinical Investigation·2005· 40 citedOpen Access
Emerging Role of RAB GTPases in Cancer and Human Disease
Cancer Research·2005· 205 cited
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
Nature Medicine·2004· 514 cited
Lysophosphatidic acid production and action: Validated targets in cancer?
Journal of Cellular Biochemistry·2004· 93 cited
Analysis of Molecular Aberrations in Ovarian Cancer Allows Novel Target Identification
Journal of Obstetrics and Gynaecology Canada·2004· 2 cited
Emerging genomic technology in cancer research: Its application in discovering and developing new therapeutic agents
2004

Frequent Co-authors

Gordon B. Mills(15), Kwai Wa Cheng(10), Jinsong Liu(8), Joe W. Gray(8), Karen Smith‐McCune(6), David A. Fishman(6), Yasuhisa Nakayama(5), Wen-Lin Kuo(5), Karen H. Lu(4), Meera Nanjundan(4), Yiling Lu(3), János L. Tanyi(3), Shuangxing Yu(3), Wen-Lin Kuo(2), Makiko Umezu‐Goto(2), Yutaka Hasegawa(2), Glenn D. Prestwich(2), Karen H. Lu(2), Anna Lapuk(1), Kyosuke Yamada(1)